Analyst Ratings for Arch Therapeutics (ARTH)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/30/2023 | Dawson James | Jason Kolbert | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.60 (0.16) |
-73.33% | Details |
| 3/14/2018 | IFS Securities | N/A | Downgrade | Outperform (Strong Buy) |
1.85 (N/A) |
0.31 (0.16) |
-48.39% | Details |
